| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Actuate Therapeutics, Inc. (ACTU) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. ACTU is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 904.8K | $2.76M | - | |
| CEO | 272.1K | $829.8K | - | |
| 10% | 196.4K | $599.1K | - | |
| 10% | 71.4K | $217.9K | - | |
| 10% | 71.4K | $217.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Kreis Leslie W.51 | 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | +56.5% | -1.4% | -10.2% |